David S Siscovick Selected Research

Proteins (Proteins, Gene)

1/2023	Plasma Proteomic Risk Markers of Incident Type 2 Diabetes Reflect Physiologically Distinct Components of Glucose-Insulin Homeostasis.
12/2019	Genome-wide meta-analysis of macronutrient intake of 91,114 European ancestry participants from the cohorts for heart and aging research in genomic epidemiology consortium.
5/2016	Fetuin-A, glycemic status, and risk of cardiovascular disease: The Multi-Ethnic Study of Atherosclerosis.
6/2013	Overlap between common genetic polymorphisms underpinning kidney traits and cardiovascular disease phenotypes: the CKDGen consortium.
6/2013	Genome-wide meta-analysis of observational studies shows common genetic variants associated with macronutrient intake.
5/2013	Fetuin-A, type 2 diabetes, and risk of cardiovascular disease in older adults: the cardiovascular health study.
5/2012	Association of fetuin-a with incident diabetes mellitus in community-living older adults: the cardiovascular health study.
12/2010	Common variants in 22 loci are associated with QRS duration and cardiac ventricular conduction.
2/2009	Genetic variations in nitric oxide synthase 1 adaptor protein are associated with sudden cardiac death in US white community-based populations.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

David S Siscovick Research Topics

Disease

72	Cardiovascular Diseases (Cardiovascular Disease) 04/2024 - 04/2002
55	Atherosclerosis 01/2023 - 04/2003
32	Coronary Disease (Coronary Heart Disease) 01/2023 - 08/2002
31	Heart Failure 09/2023 - 07/2003
30	Insulin Resistance 01/2023 - 04/2008
30	Type 2 Diabetes Mellitus (MODY) 01/2023 - 02/2010
24	Hypertension (High Blood Pressure) 04/2014 - 04/2002
23	Cardiac Sudden Death (Sudden Cardiac Arrest) 11/2023 - 10/2003
22	Stroke (Strokes) 01/2024 - 04/2002
22	Atrial Fibrillation 11/2023 - 08/2006
16	Chronic Renal Insufficiency 09/2023 - 08/2006
13	Kidney Diseases (Kidney Disease) 09/2023 - 08/2006
13	Myocardial Infarction 08/2011 - 02/2002
11	Obesity 10/2015 - 02/2009
10	Ischemic Stroke 01/2024 - 02/2002
10	Inflammation (Inflammations) 10/2015 - 03/2004
7	Fibrosis (Cirrhosis) 04/2024 - 03/2011
7	Albuminuria 01/2018 - 08/2006
7	Diabetes Mellitus 04/2017 - 05/2008
6	Peripheral Arterial Disease 01/2019 - 12/2005
6	Coronary Artery Disease (Coronary Atherosclerosis) 11/2018 - 01/2007
5	Dementia (Dementias) 01/2023 - 03/2003
5	Heart Arrest (Cardiac Arrest) 01/2018 - 02/2002
5	Sudden Death 04/2012 - 06/2003
4	Vascular Diseases (Vascular Disease) 04/2015 - 01/2009
3	Left Ventricular Hypertrophy (Ventricular Hypertrophy, Left) 05/2014 - 04/2013
3	Carotid Artery Diseases 11/2013 - 04/2005
3	Cerebrovascular Disorders (Cerebrovascular Occlusion) 02/2007 - 02/2002
2	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2024 - 01/2017
2	Cognitive Dysfunction 01/2023 - 01/2022

Drug/Important Bio-Agent (IBA)

36	Fatty Acids (Saturated Fatty Acids)IBA 09/2023 - 02/2003
34	Glucose (Dextrose)FDA LinkGeneric 07/2023 - 10/2005
33	Biomarkers (Surrogate Marker)IBA 11/2023 - 02/2002
21	Insulin (Novolin)FDA Link 01/2024 - 04/2008
21	Cystatin CIBA 12/2020 - 05/2005
17	LipidsIBA 09/2023 - 01/2008
17	Phospholipids (Phosphatides)FDA LinkGeneric 01/2023 - 02/2003
15	CreatinineIBA 12/2020 - 12/2005
14	C-Reactive ProteinIBA 01/2018 - 03/2004
13	Unsaturated Fatty Acids (Polyunsaturated Fatty Acids)IBA 01/2023 - 02/2003
11	Omega-3 Fatty Acids (Omega 3 Fatty Acids)IBA 01/2023 - 01/2005
11	25-hydroxyvitamin DIBA 01/2017 - 08/2009
11	hydroxide ionIBA 01/2017 - 05/2012
10	Vitamin D FDA LinkGeneric 01/2023 - 02/2013
10	LDL CholesterolIBA 01/2023 - 11/2006
10	Trans Fatty AcidsIBA 01/2022 - 02/2002
10	AlbuminsIBA 11/2015 - 03/2004
9	Proteins (Proteins, Gene)FDA Link 01/2023 - 02/2009
9	Triglycerides (Triacylglycerol)IBA 01/2023 - 01/2008
9	Parathyroid Hormone (Parathormone)IBA 02/2015 - 02/2009
9	Retinaldehyde (Retinal)IBA 06/2013 - 04/2003
8	trimethyloxamine (trimethylamine N-oxide)IBA 04/2024 - 01/2021
8	Nonesterified Fatty Acids (NEFA)IBA 07/2023 - 04/2012
8	alpha-Linolenic Acid (Linolenic Acid)IBA 01/2023 - 02/2003
8	alpha-2-HS-GlycoproteinIBA 01/2019 - 05/2012
8	HDL CholesterolIBA 03/2015 - 01/2008
7	Docosahexaenoic AcidsIBA 01/2024 - 02/2003
7	CeramidesIBA 11/2023 - 01/2018
7	AdiponectinIBA 10/2016 - 01/2012
7	CalciumIBA 08/2016 - 03/2006
7	Antihypertensive Agents (Antihypertensives)IBA 04/2015 - 04/2002
6	Eicosapentaenoic AcidIBA 01/2024 - 02/2003
6	SphingomyelinsIBA 11/2023 - 01/2018
6	AcidsIBA 09/2022 - 01/2007
5	Hormones (Hormone)IBA 01/2024 - 01/2012
5	Fibrinogen (Factor I)FDA Link 01/2023 - 03/2004
5	N(6)-carboxymethyllysine (carboxymethyllysine)IBA 01/2022 - 07/2014
5	palmitoleic acidIBA 10/2018 - 12/2010
5	CholesterolIBA 10/2015 - 05/2008
5	Transforming Growth Factors (Transforming Growth Factor)IBA 10/2015 - 11/2012
5	oxidized low density lipoproteinIBA 02/2014 - 07/2007
4	SphingolipidsIBA 11/2023 - 01/2018
4	Brain Natriuretic Peptide (Natrecor)FDA Link 01/2020 - 02/2011
4	Phosphates (Orthophosphate)IBA 01/2019 - 02/2009
4	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 12/2017 - 02/2007
4	PotassiumIBA 01/2017 - 05/2010
4	procollagen Type III-N-terminal peptide (PIIP)IBA 10/2015 - 05/2014
4	Collagen Type III (Type III Collagen)IBA 10/2015 - 05/2014
4	Fibroblast Growth Factor-23IBA 07/2014 - 07/2012
3	Omega-6 Fatty Acids (Omega 6 Fatty Acids)IBA 11/2023 - 12/2017
3	Arachidonic Acid (Vitamin F)IBA 01/2023 - 12/2017
3	CarbohydratesIBA 01/2023 - 01/2018
3	Advanced Glycation End ProductsIBA 01/2022 - 01/2018
3	pro-brain natriuretic peptide (1-76)IBA 01/2020 - 12/2012
3	MineralsIBA 01/2019 - 07/2011
3	Fish OilsIBA 01/2018 - 10/2013
3	Uric Acid (Urate)IBA 02/2013 - 08/2007
3	1,25-dihydroxyvitamin DIBA 09/2011 - 02/2009
3	Factor VIII (Coagulation Factor VIII)IBA 12/2009 - 03/2004
3	Interleukin-6 (Interleukin 6)IBA 07/2008 - 08/2002
3	Lipoproteins (Lipoprotein)IBA 03/2008 - 07/2007
3	Apolipoproteins E (ApoE)IBA 08/2007 - 09/2005
3	ApolipoproteinsIBA 01/2007 - 03/2003
2	AndrogensIBA 01/2024 - 01/2017
2	docosapentaenoic acidIBA 01/2023 - 03/2012
2	Betaine (C.B.B.)FDA Link 01/2022 - 01/2021
2	Choline (Choline Chloride)IBA 01/2022 - 01/2021
2	gamma-butyrobetaine (butyrobetaine)IBA 01/2022 - 01/2021
2	Carnitine (L-Carnitine)FDA LinkGeneric 01/2022 - 01/2021

Therapy/Procedure

9	Therapeutics 02/2014 - 04/2002